Skip to main content
Premium Trial:

Request an Annual Quote

Synomics Establishes Scientific Advisory Board

Premium

CAMBRIDGE, UK--Synomics, a pharmaceutical research informatics company launched in 1998, announced the formation of its scientific advisory board. Paolo Zanella, director of strategic and international relations at Synomics, will chair the board. He will be joined by Andries van Dam, a professor of computer science at Brown University; Christopher Jones, a research physicist with the CERN computer center and founding member of the new industry group Prism Forum which aims to identify emerging technologies in pharmaceutical research information systems management; and Arthur Thomas, a life science informatics expert and founder of California-based consulting firm Proteus Associates.

Synomics is developing a distributed framework for research informatics for the pharmaceutical industry that it said will "realize potential benefits of investments made in the new drug discovery technologies of genomics, bioinformatics, high-throughput screening, and combinatorial chemistry."

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.